Literature DB >> 30203128

Tamoxifen administration and risk of Parkinson's disease.

Shih-Wei Lai1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30203128     DOI： 10.1007/s00228-018-2553-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  Risk of Parkinson's disease after tamoxifen treatment.

Authors:  Jeanne C Latourelle; Merete Dybdahl; Anita L Destefano; Richard H Myers; Timothy L Lash
Journal:  BMC Neurol       Date:  2010-04-12       Impact factor: 2.474

2.  Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-10-01       Impact factor: 2.953
  2 in total
  1 in total

1.  Tamoxifen administration and the risk of Parkinsonism.

Authors:  François Montastruc; Farzin Khosrow-Khavar; Agnès Sommet; Christel Renoux; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2018-09-10       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.